Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.31, no.29, pp.3688-95, 2013 (Peer-Reviewed Journal)
Article / Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Science Citation Index Expanded, Scopus